Swarnabh Bhattacharya

Dr. Swarnabh Bhattacharya

Dana-Farber Cancer Institute, Boston, Massachusetts, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2021 in Cell Stem Cell
Verified
Journal Article
Closed access
AAAnna Altshuler
Anna Altshuler
AAAya Amitai-Lange
Aya Amitai-Lange
NTNoam Tarazi
Noam Tarazi
SDSunanda Dey
Sunanda Dey
LSLior Strinkovsky
Lior Strinkovsky
RSRuby Shalom-Feuerstein
Ruby Shalom-Feuerstein

1 December 2017 in Stem Cell Reports
Verified
Journal Article
Open access
SNSara Nagosa
Sara Nagosa
FLFriederike Leesch
Friederike Leesch
DPDaria Putin
Daria Putin
Swarnabh BhattacharyaSwarnabh Bhattacharya
Swarnabh Bhattacharya
AAAnna Altshuler
Anna Altshuler
RSRuby Shalom-Feuerstein
Ruby Shalom-Feuerstein
MiR-184 is a highly evolutionary conserved microRNA (miRNA) from fly to human. The importance of miR-184 was underscored by the discovery that point mutations in miR-184 gene led to corneal/lens blinding disease. However, miR-184-related function in vivo remained unclear. Here, we report that the miR-184 knockout mouse model displayed increased p63 expression in line with epidermal hyperplasia, while forced expression of miR-184 by stem/progenitor cells enhanced the Notch pathway and induced epidermal hypoplasia. In line, miR-184 reduced clonogenicity and accelerated differentiation of human epidermal cells. We showed that by directly repressing cytokeratin 15 (K15) and FIH1, miR-184 induces Notch activation and epidermal differentiation. The disease-causing miR-184C57U mutant failed to repress K15 and FIH1 and to induce Notch activation, suggesting a loss-of-function mechanism. Altogether, we propose that, by targeting K15 and FIH1, miR-184 regulates the transition from proliferation to early differentiation, while mis-expression or mutation in miR-184 results in impaired homeostasis.

10 December 2018 in Stem Cells
Verified
Journal Article
Open access
PDF file
Swarnabh BhattacharyaSwarnabh Bhattacharya
Swarnabh Bhattacharya
LSLaura Serror
Laura Serror
ENEshkar Nir
Eshkar Nir
DDDalbir Dhiraj
Dalbir Dhiraj
AAAnna Altshuler
Anna Altshuler
RSRuby Shalom-Feuerstein
Ruby Shalom-Feuerstein
Mutations in key transcription factors SOX2 and P63 were linked with developmental defects and postnatal abnormalities such as corneal opacification, neovascularization, and blindness. The latter phenotypes suggest that SOX2 and P63 may be involved in corneal epithelial regeneration. Although P63 has been shown to be a key regulator of limbal stem cells, the expression pattern and function of SOX2 in the adult cornea remained unclear. Here, we show that SOX2 regulates P63 to control corneal epithelial stem/progenitor cell function. SOX2 and P63 were co-expressed in the stem/progenitor cell compartments of the murine cornea in vivo and in undifferentiated human limbal epithelial stem/progenitor cells in vitro. In line, a new consensus site that allows SOX2-mediated regulation of P63 enhancer was identified while repression of SOX2 reduced P63 expression, suggesting that SOX2 is upstream to P63. Importantly, knockdown of SOX2 significantly attenuated cell proliferation, long-term colony-forming potential of stem/progenitor cells, and induced robust cell differentiation. However, this effect was reverted by forced expression of P63, suggesting that SOX2 acts, at least in part, through P63. Finally, miR-450b was identified as a direct repressor of SOX2 that was required for SOX2/P63 downregulation and cell differentiation. Altogether, we propose that SOX2/P63 pathway is an essential regulator of corneal stem/progenitor cells while mutations in SOX2 or P63 may disrupt epithelial regeneration, leading to loss of corneal transparency and blindness. Stem Cells 2019;37:417–429

24 April 2023 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
Swarnabh BhattacharyaSwarnabh Bhattacharya
Swarnabh Bhattacharya
AMAbhishek Mukherjee
Abhishek Mukherjee
SPSabrina Pisano
Sabrina Pisano
SDShalini Dimri
Shalini Dimri
EKEman Knaane
Eman Knaane
RSRuby Shalom-Feuerstein
Ruby Shalom-Feuerstein
The cell fate decisions of stem cells (SCs) largely depend on signals from their microenvironment (niche). However, very little is known about how biochemical niche cues control cell behavior in vivo. To address this question, we focused on the corneal epithelial SC model in which the SC niche, known as the limbus, is spatially segregated from the differentiation compartment. We report that the unique biomechanical property of the limbus supports the nuclear localization and function of Yes-associated protein (YAP), a putative mediator of the mechanotransduction pathway. Perturbation of tissue stiffness or YAP activity affects SC function as well as tissue integrity under homeostasis and significantly inhibited the regeneration of the SC population following SC depletion. In vitro experiments revealed that substrates with the rigidity of the corneal differentiation compartment inhibit nuclear YAP localization and induce differentiation, a mechanism that is mediated by the TGFβ−SMAD2/3 pathway. Taken together, these results indicate that SC sense biomechanical niche signals and that manipulation of mechano-sensory machinery or its downstream biochemical output may bear fruits in SC expansion for regenerative therapy.

1 March 2018 in Stem Cell Reports
Verified
Journal Article
Open access
AAAnna Altshuler
Anna Altshuler
MVMila Verbuk
Mila Verbuk
Swarnabh BhattacharyaSwarnabh Bhattacharya
Swarnabh Bhattacharya
IAIfat Abramovich
Ifat Abramovich
RHRoni Haklai
Roni Haklai
RSRuby Shalom-Feuerstein
Ruby Shalom-Feuerstein
The transition from naive to primed state of pluripotent stem cells is hallmarked by epithelial-mesenchymal transition, metabolic switch from oxidative phosphorylation to aerobic glycolysis, and changes in the epigenetic landscape. Since these changes are also seen as putative hallmarks of neoplastic cell transformation, we hypothesized that oncogenic pathways may be involved in this process. We report that the activity of RAS is repressed in the naive state of mouse embryonic stem cells (ESCs) and that all three RAS isoforms are significantly activated upon early differentiation induced by LIF withdrawal, embryoid body formation, or transition to the primed state. Forced expression of active RAS and RAS inhibition have shown that RAS regulates glycolysis, CADHERIN expression, and the expression of repressive epigenetic marks in pluripotent stem cells. Altogether, this study indicates that RAS is located at a key junction of early ESC differentiation controlling key processes in priming of naive cells.

8 January 2025 in Nature
Verified
Journal Article
Closed access
PDF file
LGLiam Gaynor
Liam Gaynor
HSHarshabad Singh
Harshabad Singh
GTGuodong Tie
Guodong Tie
KBKrithika Badarinath
Krithika Badarinath
SMShariq Madha
Shariq Madha
RSRamesh A. Shivdasani
Ramesh A. Shivdasani